GPs in Scotland have wider type-2 diabetes treatment choice

GPs in Scotland now have a wider choice of treatments for type-2 diabetes following acceptance of the dipeptidyl peptidase 4 (DPP-4) inhibitor sitagliptin by the Scottish Medicines Consortium (SMC).

SMC accepted sitagliptin to treat type-2 diabetes in combination with a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate control of blood sugar. 

It also accepted it for use in combination with a sulphonylurea when diet and exercise plus the highest tolerated dose of sulphonylurea does not provide adequate control of blood sugar and when metformin is not suitable.

The SMC noted that, although sitagliptin is also licensed for use in combination with thiazolidinedione drugs, the manufacturer’s submission related only to the use of sitagliptin in combination with sulphonylureas with or without metformin.

The SMC said it therefore could not recommend the use of sitagliptin in combination with thiazolidinediones.

tom.moberly@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

NHS England to redesign GP appraisal in light of COVID-19 pandemic

NHS England to redesign GP appraisal in light of COVID-19 pandemic

GP appraisals are being redesigned to have a greater focus on wellbeing and reduced...

Primary care to lose millions in funding unless PCNs hit recruitment targets in pandemic

Primary care to lose millions in funding unless PCNs hit recruitment targets in pandemic

Hundreds of millions of pounds could be lost to primary care if primary care networks...

Practices told to prepare for 'major expansion' of flu vaccination as QOF pared back for 2020/21

Practices told to prepare for 'major expansion' of flu vaccination as QOF pared back for 2020/21

GP practices have been told to 'gear up for a major expansion of the winter flu programme'...

NHS England unveils GP contract plans for second phase of COVID-19 response

NHS England unveils GP contract plans for second phase of COVID-19 response

GPs have been told to re-start health checks and other suspended services as NHS...

More than 80% of patients report 'good' overall experience of general practice

More than 80% of patients report 'good' overall experience of general practice

Public satisfaction with GP services remains high, with 82% of patients reporting...

GPs condemn 'deafening silence' from chancellor on COVID support funding

GPs condemn 'deafening silence' from chancellor on COVID support funding

GP leaders have condemned a 'deafening silence' on COVID-19 relief funding for general...